Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

NLS Pharmaceutics Ltd. Warrant (NLSPW)

https://www.nlspharma.com

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/29/2021

Market Cap

4,573,904

Shares Outstanding

32,430,000

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Beta

-0.5310

Last Div

0.0000

Range

0.005-0.17

Chg

-0.0187

Avg Vol

13495

Mkt Cap

4573904

Exch

NASDAQ

Country

CH

Phone

N/A

DCF Diff

0.1905

DCF

-0.0193

Div Yield

0.0000

P/S

0.0000

EV Multiple

-0.7618

P/FV

-0.6491

Div Yield %

0.0000

P/E

-0.4710

PEG

-0.0076

Payout

0.0000

Current Ratio

0.2302

Quick Ratio

0.2302

Cash Ratio

0.1133

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

148250.3427

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0000

ROA

-6.5914

ROE

1.8554

ROCE

1.9442

NI/EBT

1.0000

EBT/EBIT

1.0309

EBIT/Rev

0.0000

Debt Ratio

0.8847

D/E

-0.1849

LT Debt/Cap

0.0000

Total Debt/Cap

-0.2269

Int Coverage

-81.3422

CF/Debt

-5.9278

Equity Multi

-0.2090

Rec Turnover

0.0000

Pay Turnover

0.0025

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-0.2986

FCF/Share

-0.2986

Cash/Share

0.0277

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

-5.9278

ST Coverage

-5.9278

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

-0.6491

P/B

-0.6491

P/S

0.0000

P/E

-0.4710

P/FCF

-0.8519

P/OCF

-0.5920

P/CF

-0.5920

PEG

-0.0076

P/S

0.0000

EV Multiple

-0.7618

P/FV

-0.6491

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation